News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MorphoSys AG Reports Results for Fiscal Year 2013



2/28/2014 9:19:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MARTINSRIED / MUNICH, Germany, Feb. 28, 2014 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced financial results for the year ending 31 December 2013. Group revenues from continuing operations amounted to EUR 78.0 million and earnings before interest and taxes (EBIT) reached EUR 9.9 million. The consolidated net profit amounted to EUR 13.3 million, translating into earnings per share (EPS) of EUR 0.54. On 31 December 2013, the Company held liquid funds and marketable securities, as well as other financial assets, in the amount of EUR 390.7 million, compared to EUR 135.7 million on 31 December 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES